Opus Genetics, Inc. (IRD) — Cash Flow Quality Index
Opus Genetics, Inc. (IRD) has a Cash Flow Quality Index of -0.54x as of September 2023. Operating cash flow of $-3.00 Million is below net income of $5.56 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore IRD total asset value for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Opus Genetics, Inc. Cash Flow Quality Index (2022–2022)
Historical Cash Flow Quality Index for Opus Genetics, Inc. across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Opus Genetics, Inc. (IRD) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Opus Genetics, Inc. (2022–2022)
Year-by-year earnings quality comparison for Opus Genetics, Inc.. For live market cap and the full company financial profile, see IRD stock market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 0.80x | $14.31 Million | $17.89 Million | — |